Research programme: DKK1 antagonists - Siena Biotech
Latest Information Update: 16 Jul 2016
At a glance
- Originator Siena Biotech
- Class Small molecules
- Mechanism of Action Wnt protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in Italy
- 07 Nov 2007 Preclinical trials in Alzheimer's disease in Italy (unspecified route)